Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer - Trial NCT06232122
Access comprehensive clinical trial information for NCT06232122 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Recruiting. The study focuses on Ovarian Cancer. Target enrollment is 45 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chang Gung Memorial Hospital
Timeline & Enrollment
N/A
Aug 01, 2022
Jul 31, 2028
Primary Outcome
Diagnostic performances of 68Ga-FAPI and 18F-FDG PET/CT for ovarian cancer recurrence after one year from PET/CT imaging in Per-Protocol Analysis Dataset
Summary
A prospective cohort imaging study in a single institution to evaluate 68Ga- FAPI-46 and
 18F-FDG PET/CT imaging for detecting recurrent tumor lesions in patients of ovarian cancer
 with CA125 elevation from complete response after therapy
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06232122
Non-Device Trial